Literature DB >> 19941698

Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain.

Alexia Polissidis1, Olga Chouliara, Andreas Galanopoulos, Georgia Rentesi, Maria Dosi, Thomas Hyphantis, Marios Marselos, Zeta Papadopoulou-Daifoti, George G Nomikos, Christina Spyraki, Eleni T Tzavara, Katerina Antoniou.   

Abstract

This study explored the behavioural, neurochemical and molecular effects of Delta9-tetrahydrocannabinol (Delta9-THC) and WIN55,212-2, in two rat phenotypes, distinguished on the basis of their vertical activity upon exposure to a novel environment, as high responders (HR) and low responders (LR). Motor effects were assessed under habituated vs. non-habituated conditions. Dopaminergic activity and DARPP-32 phosphorylation were measured in the dorsal striatum, nucleus accumbens, prefrontal cortex and amygdala. These cannabinoids influenced motor activity in a biphasic manner, i.e. low doses stimulated, whereas high doses suppressed motor activity. Dopamine (DA) biosynthesis was increased in most brain regions studied following Delta9-THC administration mainly in HR rats, and low-dose WIN55,212-2 increased DA biosynthesis in HR rats only. Both high and low doses of Delta9-THC increased DARPP-32 phosphorylation in most brain regions studied in both phenotypes, an effect that was also observed following high-dose WIN55,212-2 administration only in the striatum. The present results provide further support for a key role of cannabinoids in the regulation of motoric responses and elements of dopaminergic neurotransmission and reveal their complex differential effects in distinct rat phenotypes, as seen with other drugs of abuse.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19941698     DOI: 10.1017/S1461145709991003

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  9 in total

1.  Effect of prior foot shock stress and Δ9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats.

Authors:  Erin M Rock; Cheryl L Limebeer; Gavin N Petrie; Lauren A Williams; Raphael Mechoulam; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2017-04-20       Impact factor: 4.530

2.  The cannabinoid agonist WIN55212-2 decreases L-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats.

Authors:  Alex Martinez; Teresa Macheda; Maria Grazia Morgese; Luigia Trabace; Andrea Giuffrida
Journal:  Neurosci Res       Date:  2011-12-17       Impact factor: 3.304

Review 3.  New insights on endocannabinoid transmission in psychomotor disorders.

Authors:  Andrea Giuffrida; Alexandre Seillier
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-04-10       Impact factor: 5.067

Review 4.  Translational models of cannabinoid vapor exposure in laboratory animals.

Authors:  Catherine F Moore; Jeffrey W Stiltner; Catherine M Davis; Elise M Weerts
Journal:  Behav Pharmacol       Date:  2022-04-01       Impact factor: 2.293

5.  In vivo manganese exposure modulates Erk, Akt and Darpp-32 in the striatum of developing rats, and impairs their motor function.

Authors:  Fabiano M Cordova; Aderbal S Aguiar; Tanara V Peres; Mark W Lopes; Filipe M Gonçalves; Aline P Remor; Samantha C Lopes; Célso Pilati; Alexandra S Latini; Rui D S Prediger; Keith M Erikson; Michael Aschner; Rodrigo B Leal
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

6.  Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2.

Authors:  Eleni Fanarioti; Maria Mavrikaki; George Panagis; Ada Mitsacos; George G Nomikos; Panagiotis Giompres
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-07       Impact factor: 5.176

7.  Forced swim test induces divergent global transcriptomic alterations in the hippocampus of high versus low novelty-seeker rats.

Authors:  Pothitos M Pitychoutis; Despina Sanoudou; Margarita Papandreou; Dimitris Nasias; Marianna Kouskou; Craig R Tomlinson; Panagiotis A Tsonis; Zeta Papadopoulou-Daifoti
Journal:  Hum Genomics       Date:  2014-02-25       Impact factor: 4.639

8.  The anxiolytic effects of valtrate in rats involves changes of corticosterone levels.

Authors:  Shu-Ning Shi; Jin-Li Shi; Yong Liu; Yan-Li Wang; Chun-Guo Wang; Wen-Hui Hou; Jian-You Guo
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-20       Impact factor: 2.629

9.  The nucleus reuniens: a key node in the neurocircuitry of stress and depression.

Authors:  V Kafetzopoulos; N Kokras; I Sotiropoulos; J F Oliveira; H Leite-Almeida; A Vasalou; V M Sardinha; Z Papadopoulou-Daifoti; O F X Almeida; K Antoniou; N Sousa; C Dalla
Journal:  Mol Psychiatry       Date:  2017-04-11       Impact factor: 15.992

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.